Key result
HeartMate III LVAD and OHT successfully stabilize end-stage heart failure in a case report.
Why the study?
End-stage heart failure is a progressive disease associated with a high risk of death within the first 6-12 months following diagnosis.
Case Report (n=2)
No
This case report demonstrates the successful management of end-stage heart failure using LVAD and orthotopic heart transplantation in a Romanian center.
Answers are grounded in this paper and cite their sources.
Supports feasibility in select end-stage HF cases; leaves open generalizability and need for prospective data.
Introduction. L'insuffisance cardiaque est un syndrome clinique caus par des anomalies cardiaques structurelles et/ou fonctionnelles, entranant un dbit cardiaque rduit et/ou des pressions intracardiaques leves au repos ou pendant le stress. Il s'agit d'une maladie volutive avec un risque lev de dcs dans les 6 12 premiers mois suivant le diagnostic d'insuffisance cardiaque en phase terminale. Prsentation des cas. Nous prsentons l'implantation russie d'un dispositif d'assistance ventriculaire gauche HEART MATE III chez un homme de 54 ans atteint de cardiomyopathie ischmique et d'insuffisance cardiaque en phase terminale, et une transplantation cardiaque chez un homme de 31 ans atteint ABSTRACT Introduction. Heart failure (HF) is a clinical syndrome caused by structural and/or functional cardiac abnormalities, resulting in a reduced cardiac output and/or elevated intracardiac pressures at rest or during stress. It is a progressive disease with a high risk of death in the first 6-12 months after the diagnosis of end stage HF. Cases presentation. We present the successful implantation of a left-ventricular assist device (LVAD) HEART MATE III in a 54-year-old male with ischemic cardiomyopathy and end stage HF, and a heart transplant in a 31-year-old male with non-ischemic dilated cardiomyopathy and end stage HF. Both procedures were guided by experienced surgeons and the overall management was according to the current standardised protocol.
No takes yet. Share an insight, caveat, or question.
MOLDOVAN et al. (2022) conducted a case report in End-stage heart failure (n=2). Left ventricular assist device (HeartMate III) and orthotopic heart transplantation was evaluated. Implantation of a HeartMate III left ventricular assist device and an orthotopic heart transplant successfully stabilized and improved the clinical condition of two men with end-stage heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: